Allgens(SH:688613) Sou Hu Cai Jing·2026-02-10 00:22Core Viewpoint - The stock of Aojing Medical (688613) has shown a significant increase, closing at 24.17 yuan on February 9, 2026, with an 8.58% rise, indicating positive market sentiment towards the company [1]. Group 1: Stock Performance - On February 9, 2026, Aojing Medical's trading volume was 79,600 hands, with a total transaction amount of 189 million yuan [1]. - The stock's turnover rate was 5.81%, reflecting active trading [1]. Group 2: Capital Flow - On February 9, 2026, the net inflow of main funds was 2.45 million yuan, accounting for 1.29% of the total transaction amount, while retail investors saw a net inflow of 2.69 million yuan, representing 1.42% of the total [1]. - Over the past five days, the financing data showed a net purchase of 1.41 million yuan on that day, with a cumulative net purchase of 5.72 million yuan over three days [2]. Group 3: Financial Performance - For the first three quarters of 2025, Aojing Medical reported a main revenue of 156 million yuan, a year-on-year increase of 5.22%, and a net profit attributable to shareholders of 13.94 million yuan, up 185.19% [3]. - In the third quarter of 2025, the company achieved a single-quarter main revenue of 56.02 million yuan, a 16.54% increase year-on-year, and a net profit of 5.97 million yuan, reflecting a 237.64% rise [3]. - The company's gross profit margin stood at 68.9%, indicating strong profitability in its operations [3].